FDAFDA · Food and drugs·Recall number D-0435-2023
Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01
Published March 15, 2023 · Recall initiated: February 28, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not elsewhere classified
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HEPARIN SODIUM
- Manufacturer
- Sagent Pharmaceuticals Inc
- Distributor
- USA Nationwide
- Lot
- Lot#: WP201, Exp 2/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.